Literature DB >> 11778000

The interval between pregnancies and the risk of preeclampsia.

Rolv Skjaerven1, Allen J Wilcox, Rolv T Lie.   

Abstract

BACKGROUND: The risk of preeclampsia is generally lower in second pregnancies than in first pregnancies, but not if the mother has a new partner for the second pregnancy. One explanation is that the risk is reduced with repeated maternal exposure and adaptation to specific antigens from the same partner. However, the difference in risk might instead be explained by the interval between births. A longer interbirth interval may be associated with both a change of partner and a higher risk of preeclampsia.
METHODS: We used data from the Medical Birth Registry of Norway, a population-based registry that includes births that occurred between 1967 and 1998. We studied 551,478 women who had two or more singleton deliveries and 209,423 women who had three or more singleton deliveries.
RESULTS: Preeclampsia occurred during 3.9 percent of first pregnancies, 1.7 percent of second pregnancies, and 1.8 percent of third pregnancies when the woman had the same partner. The risk in a second or third pregnancy was directly related to the time that had elapsed since the preceding delivery, and when the interbirth interval was 10 years or more, the risk approximated that among nulliparous women. After adjustment for the presence or absence of a change of partner, maternal age, and year of delivery, the odds ratio for preeclampsia for each one-year increase in the interbirth interval was 1.12 (95 percent confidence interval, 1.11 to 1.13). In unadjusted analyses, a pregnancy involving a new partner was associated with higher risk of preeclampsia, but after adjustment for the interbirth interval, the risk of preeclampsia was reduced (odds ratio for preeclampsia with a change of partner, 0.73; 95 percent confidence interval, 0.66 to 0.81).
CONCLUSIONS: The protective effect of previous pregnancy against preeclampsia is transient. After adjustment for the interval between births, a change of partner is not associated with an increased risk of preeclampsia.

Entities:  

Mesh:

Year:  2002        PMID: 11778000     DOI: 10.1056/NEJMoa011379

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  68 in total

1.  Interpregnancy interval might affect the risk of childhood atopy.

Authors:  Ganesa Wegienka; Stephanie J London; Christine Cole Johnson; Dennis R Ownby
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

Review 2.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.

Authors:  Kirsten Duckitt; Deborah Harrington
Journal:  BMJ       Date:  2005-03-02

Review 3.  Preeclampsia: a view through the danger model.

Authors:  Elizabeth A Bonney
Journal:  J Reprod Immunol       Date:  2007-05-04       Impact factor: 4.054

4.  Male reproductive proteins and reproductive outcomes.

Authors:  Roberta B Ness; David A Grainger
Journal:  Am J Obstet Gynecol       Date:  2008-01-14       Impact factor: 8.661

5.  Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy.

Authors:  Samantha D Smith; Caroline E Dunk; John D Aplin; Lynda K Harris; Rebecca L Jones
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

6.  Renal involvement in nail-patella syndrome: report of three cases.

Authors:  Puneet Sood; Maria C Rojas; Zvi Talor
Journal:  Int Urol Nephrol       Date:  2009-03-19       Impact factor: 2.370

7.  Effects of interpregnancy interval on blood pressure in consecutive pregnancies.

Authors:  Rafael T Mikolajczyk; Jun Zhang; Jessie Ford; Jagteshwar Grewal
Journal:  Am J Epidemiol       Date:  2008-05-20       Impact factor: 4.897

8.  A Comparison of 2-Methoxyestradiol Value in Women with Severe Preeclampsia Versus Normotensive Pregnancy.

Authors:  John Wantania; Ahsanuddin Attamimi; Rukmono Siswishanto
Journal:  J Clin Diagn Res       Date:  2017-03-01

9.  VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population.

Authors:  Melissa D Amosco; Van Anthony M Villar; Justin Michael A Naniong; Lara Marie G David-Bustamante; Pedro A Jose; Cynthia P Palmes-Saloma
Journal:  Clin Exp Hypertens       Date:  2016-09-26       Impact factor: 1.749

10.  Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.

Authors:  Anne P Starling; Stephanie M Engel; David B Richardson; Donna D Baird; Line S Haug; Alison M Stuebe; Kari Klungsøyr; Quaker Harmon; Georg Becher; Cathrine Thomsen; Azemira Sabaredzovic; Merete Eggesbø; Jane A Hoppin; Gregory S Travlos; Ralph E Wilson; Lill I Trogstad; Per Magnus; Matthew P Longnecker
Journal:  Am J Epidemiol       Date:  2014-02-20       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.